North American multicenter experience with the Flow Redirection Endoluminal Device in the treatment of intracranial aneurysms

CONCLUSIONS: As the first large-scale North American multicenter FRED experience, this study confirmed the ease of successful FRED deployment but suggested lower efficacy and a higher rate of complications than reported by previous European and South American studies on FRED and other flow-diverting devices. The authors recommend judicious use of this device until future studies can better elucidate the long-term outcomes of FRED treatment.PMID:36087324 | DOI:10.3171/2022.7.JNS221371

Source: Journal of Neurosurgery - September 10, 2022 Category: Neurosurgery Authors: MirHojjat Khorasanizadeh Max Shutran Clemens M Schirmer Mohamed M Salem Andrew J Ringer Ramesh Grandhi Alim P Mitha Michael R Levitt Brian T Jankowitz Philipp Taussky Ajith J Thomas Justin M Moore Christopher S Ogilvy Source Type: research